Sitemap

November 16, 2003 Articles

Filter by Available Specialty
  1. Conservative treatment of lacrimal gland malignancies seen increasing
  2. CrystaLens receives first U.S. accommodative IOL approval
  3. Neuroprotective drugs may hold hope for optic neuropathies, surgeon says
  4. PDT with SnET2 trial shows promise, study finds